
# The Looming Crisis of Primary Drug Resistance in India: A Living Review (2025â€“2030)

[![Python](https://img.shields.io/badge/Python-3.9%2B-blue)](https://www.python.org/)
[![Streamlit](https://img.shields.io/badge/Dashboard-Streamlit-FF4B4B)](https://streamlit.io/)
[![Status](https://img.shields.io/badge/Status-Active-success)]()

**A Multi-Model Forecasting, Meta-Analytical, and Policy Scenario Assessment Platform**

This repository contains the code, data, and interactive tools for a comprehensive "Living Review" of the Drug-Resistant Tuberculosis (DR-TB) epidemic in India. It serves as the digital companion to the research manuscript authored by **Dr. Siddalingaiah H. S.**, providing transparency, reproducibility, and real-time scenario modeling capabilities for policymakers and researchers.

---

## ğŸ¯ Project Overview

India stands at a critical juncture in its TB elimination journey. As we approach the 2025 targets, our research reveals a fundamental shift in the epidemic's nature: **Primary Transmission** (direct infection with resistant strains) is overtaking **Acquired Resistance** (treatment failure) as the dominant driver of MDR-TB.

This project aims to:
1.  **Forecast** the trajectory of TB and DR-TB notifications up to 2030 using advanced ML ensembles.
2.  **Quantify** the "New Case Paradox" â€” the rising proportion of resistant cases among treatment-naÃ¯ve patients.
3.  **Map** sub-national hotspots to guide resource allocation.
4.  **Simulate** the impact of policy interventions (Active Case Finding, TPT, Universal BPaL) on future burden.

---

## ğŸ—ï¸ Methodology

This research employs a rigorous mixed-methods approach:

*   **Evidence Synthesis:** A **Rapid Meta-Analysis** of 5 recent prevalence studies (N > 150,000) validated a baseline primary resistance rate of **3.64%**.
*   **Ensemble Forecasting:** A weighted consensus model combining:
    *   *Holt-Winters Exponential Smoothing* (Trend/Seasonality)
    *   *ARIMA* (Auto-regressive dynamics)
    *   *XGBoost Linear* (Structural growth extrapolation)
    *   *Bayesian Ridge Regression* (95% Uncertainty Quantification)
*   **Scenario Modeling:** Deterministic sensitivity analysis simulating three futures:
    1.  *Status Quo*
    2.  *Treatment Optimization (Universal BPaL/M)*
    3.  *Combination Strategy (Prevention First + Treatment)*

---

## ğŸ“Š Interactive Dashboard

We have developed a **Streamlit Dashboard** to allow users to interact with the data directly.

### Features:
*   **National Forecast:** Zoom into the 2025â€“2030 trajectory with uncertainty bounds.
*   **State Hotspots:** Sort states by *Volume* (Total Cases) or *Intensity* (% Resistance) to identify high-priority zones.
*   **Policy Simulator:** "What-If" calculator to adjust TPT and BPaL coverage efficiency and see the impact on lives saved.

### How to Run Locally:

1.  **Clone the Repository:**
    ```bash
    git clone https://github.com/hssling/drtb_projections_modelling.git
    cd drtb_projections_modelling
    ```

2.  **Install Dependencies:**
    ```bash
    pip install -r requirements_dashboard.txt
    ```

3.  **Launch Dashboard:**
    ```bash
    streamlit run dashboard_app.py
    ```

---

## ğŸ“‚ Repository Structure

```text
â”œâ”€â”€ analysis_results/           # CSV Data generated by the models
â”‚   â”œâ”€â”€ advanced_forecast_refined.csv
â”‚   â”œâ”€â”€ state_drtb_forecasts_split_2030.csv
â”‚   â””â”€â”€ policy_scenario_data.csv
â”‚
â”œâ”€â”€ manuscript_assets/          # High-Resolution Figures (PNG)
â”‚   â”œâ”€â”€ Figure_1_Combined_Forecast_Scenarios.png
â”‚   â”œâ”€â”€ Figure_2_Chloropleth_Revised.png (Maps)
â”‚   â”œâ”€â”€ Figure_3_DRTB_Dynamics.png (Diagnostic Gap)
â”‚   â””â”€â”€ Figure_4_Rapid_Meta_Analysis.png
â”‚
â”œâ”€â”€ dashboard_app.py            # Streamlit Application Source Code
â”œâ”€â”€ consolidate_figures.py      # Script to generate multi-panel figures
â”œâ”€â”€ run_advanced_ml_forecast.py # Core Forecasting Logic
â”œâ”€â”€ requirements_dashboard.txt  # Python Dependencies
â”‚
â”œâ”€â”€ final_comprehensive_manuscript_v6.docx  # Full Academic Manuscript (Latest)
â”œâ”€â”€ Figures_and_Tables_Final_V4.docx        # Submission-ready Figures Document
â””â”€â”€ AUTHORS.md                  # Author Affiliations
```

---

## ğŸ—ï¸ Key Findings & Policy Implications

| Finding | Interpretation | Policy Recommendation |
| :--- | :--- | :--- |
| **New Case Paradox** | By 2030, **67%** of DR-TB cases will be in *new* patients. | **Stop Risk-Based Screening.** Implement Universal Upfront NAAT for *all* patients. |
| **Hotspot Heterogeneity** | **Maharashtra** & **Delhi** have distinct high-intensity epidemics compared to UP/Bihar. | **Differential Strategies:** Focus on transmission breaking in urban metros; volume management in plains. |
| **Cost of Inaction** | Status Quo leads to **3 Million** cases/year by 2030. | **Prevention is Key.** Curative approaches alone (BPaL) save only 11%. Combination (TPT+ACF) saves 47%. |

---

## âœï¸ Authors & Contact

**Dr. Siddalingaiah H. S.**  
Professor, Community Medicine  
Shridevi Institute of Medical Sciences and Research Hospital  
Tumkur, Karnataka, India  
ğŸ“§ *Email:* [hssling@yahoo.com](mailto:hssling@yahoo.com)

---

## ğŸ“œ License & Citation

This project is open-source. Please cite the accompanying manuscript when using this data.

**Reference:**
Siddalingaiah H. S. (2025). *The Looming Crisis of Primary Drug Resistance: A Multi-Model Forecasting, Meta-Analytical, and Policy Scenario Assessment of Tuberculosis in India (2025â€“2030)*. [Manuscript in Preparation].
